Cargando…

Secondary cytoreductive surgery in recurrent clear cell carcinoma of the endometrium: A case report

INTRODUCTION & IMPORTANCE: Endometrial cancer with high-risk histology is associated with a majority of recurrences and death. However, unlike other cancers, such as ovarian, there is a paucity of research demonstrating the benefits of secondary cytoreduction. In this case report we aim to aid i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Connie, Jenkins, Nicole, Aikman, Noelle, ElSahwi, Karim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382725/ https://www.ncbi.nlm.nih.gov/pubmed/37418794 http://dx.doi.org/10.1016/j.ijscr.2023.108412

Ejemplares similares

erbB2 Overexpression in Uterine Serous Cancer: A Molecular Target for Trastuzumab Therapy
por: ElSahwi, Karim S., et al.
Publicado: (2011)

Vaginal Cuff Dehiscence in Robotic-Assisted Total Hysterectomy
por: Kashani, Shabnam, et al.
Publicado: (2012)

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
por: Onda, T, et al.
Publicado: (2005)

The current role of secondary cytoreductive surgery for recurrent ovarian cancer
por: de Bree, Eelco, et al.
Publicado: (2022)

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2022)

Challenges to Intraoperative Evaluation of Endometrial Cancer
por: Giglio, Alexandra, et al.
Publicado: (2020)

Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
por: Zang, Rongyu, et al.
Publicado: (2019)

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer
por: Certelli, Camilla, et al.
Publicado: (2023)

The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma
por: Nunes, Rafael Leite, et al.
Publicado: (2023)

Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer
por: Jiang, Caixia, et al.
Publicado: (2021)

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
por: Bogani, Giorgio, et al.
Publicado: (2018)

Prognostic factors in clear cell carcinoma of endometrium: analysis of 55 cases
por: Loizzi, Vera, et al.
Publicado: (2021)

Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in 27 Cases
por: Zhang, Zhiyang, et al.
Publicado: (2021)

Spontaneous Regression of Recurrent Undifferentiated Carcinoma of the Endometrium
por: Ishii, Tadashi, et al.
Publicado: (2019)

Clear Cell Carcinoma of the Endometrium Causing Paraneoplastic Retinopathy: Case Report and Review of the Literature
por: Cybulska, Paulina, et al.
Publicado: (2011)

Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer
por: Jeong, Soo Young, et al.
Publicado: (2019)

Successful treatment of platinum refractory ovarian clear cell carcinoma with secondary cytoreductive surgery and implantable transponder placement to facilitate targeted volumetric arc radiation therapy
por: Fehniger, Julia, et al.
Publicado: (2018)

The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients
por: So, Makiko, et al.
Publicado: (2019)

Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique
por: Macciò, Antonio, et al.
Publicado: (2021)

Recurrent ovarian cancer with multiple lymph nodes metastases successfully treated with lymphadenectomy as secondary cytoreductive surgery: A case report
por: Nagano, Hiroaki, et al.
Publicado: (2014)

Variants of in situ carcinoma of the endometrium: Clear cell and gastrointestinal types, with a review of the literature
por: Abada, Evi, et al.
Publicado: (2022)

Prognostic Value of Peritoneal Cytology in Stage I Serous and Clear Cell Carcinoma of the Endometrium
por: Yang, Jie, et al.
Publicado: (2023)

Pure and mixed clear cell carcinoma of the endometrium: A molecular and immunohistochemical analysis study
por: Reijnen, Casper, et al.
Publicado: (2023)

Conditional survival of metastatic clear cell renal cell carcinoma: How prognosis evolves after cytoreductive surgery of primary tumor
por: Shen, Haixiang, et al.
Publicado: (2021)

Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma
por: Chakiryan, Nicholas H., et al.
Publicado: (2022)

Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Mercier, F., et al.
Publicado: (2018)

Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review
por: Conte, Carmine, et al.
Publicado: (2021)

Recurrent metastatic clear cell renal carcinoma with sarcomatoid dedifferentiation treated with surgery and Cabozantinib
por: Boustany, Johnny, et al.
Publicado: (2020)

Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis
por: Suda, Kazuaki, et al.
Publicado: (2020)

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
por: Murakami, Kosuke, et al.
Publicado: (2021)

Clear Cell Carcinoma of the Endometrium in a Patient Presenting with Postmenopausal Bleeding but Negative Endometrial Biopsy
por: Silwal, Swechchha, et al.
Publicado: (2021)

Morbidity and mortality in women with advanced ovarian cancer who underwent primary cytoreductive surgery compared to cytoreductive surgery for recurrent disease: a meta-analysis
por: Bartels, Helena C., et al.
Publicado: (2019)

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort
por: Zang, R Y, et al.
Publicado: (2011)

The survival outcome and complication of secondary cytoreductive surgery plus chemotherapy in recurrent ovarian cancer: a systematic review and meta-analysis
por: Ding, Ting, et al.
Publicado: (2021)

Recurrent Implantation Failure: The Role of the Endometrium
por: Timeva, Tanya, et al.
Publicado: (2014)

Salvage cytoreductive surgery for patients with recurrent endometrial cancer: a retrospective study
por: Ren, Yulan, et al.
Publicado: (2014)

Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms
por: Karpes, J. B., et al.
Publicado: (2020)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_0uectslid5m6gc2dhmdpqunbau